Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Max Wattenberg, MD

    Address513 Parnassus Ave, Med Sci
    San Francisco CA 94122
    vCardDownload vCard

      Collapse Biography 
      Collapse Awards and Honors
      Radiation Therapy Oncology Group Semiannual Meeting - Philadelphia 2013Invited Speaker - Radiation for Therapeutic Targets
      University of Louisville 2012 - 2014KMA Alliance Scholarship Award

      Collapse Overview 
      Collapse Overview
      BA in Biology, University of Louisville (2009)
      Research fellow, Medical Scholars Research Program, National Institutes of Health (2012-2013)
      MD, University of Louisville School of Medicine (2014)
      Intern, Department of Medicine, University of California, San Francisco (2014-2015)

      Collapse Interests
      I have a general interest in clinical solid tumor oncology and translation research. My specific interests within translation research include mechanisms of checkpoint inhibitor therapy, novel imaging techniques to monitor response to immunotherapy and immunometabolism.

      Collapse ORNG Applications 
      Collapse Twitter

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Wattenberg MM, Williams M, Haber L. . In the Chest but not of the Chest. Journal of General Internal Medicine. 2016.
      2. Wattenberg MM, Fong L, Madan RA, Gulley JL, et al. Immunotherapy in genitourinary malignancies. Curr Opin Urol. 2016 Jul 28. PMID: 27471994.
        View in: PubMed
      3. Kanagavelu S, Gupta S, Wu X, Philip S, Wattenberg MM, Hodge JW, Couto MD, Chung KD, Ahmed MM. In vivo effects of lattice radiation therapy on local and distant lung cancer: potential role of immunomodulation. Radiat Res. 2014 Aug; 182(2):149-62. PMID: 25036982.
        View in: PubMed
      4. Wattenberg MM, Fahim A, Ahmed MM, Hodge JW. Unlocking the combination: potentiation of radiation-induced antitumor responses with immunotherapy. Radiat Res. 2014 Aug; 182(2):126-38. PMID: 24960415; PMCID: PMC4128341.
      5. Bernstein MB, Garnett CT, Zhang H, Velcich A, Wattenberg MM, Gameiro SR, Kalnicki S, Hodge JW, Guha C. Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactions. Cancer Biother Radiopharm. 2014 May; 29(4):153-61. PMID: 24693958; PMCID: PMC4024843.
      6. Wattenberg MM, Kwilas AR, Gameiro SR, Dicker AP, Hodge JW. Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets. Br J Cancer. 2014 Mar 18; 110(6):1472-80. PMID: 24556625; PMCID: PMC3960628.
      7. Gameiro SR, Jammeh ML, Wattenberg MM, Tsang KY, Ferrone S, Hodge JW. Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing. Oncotarget. 2014 Jan 30; 5(2):403-16. PMID: 24480782; PMCID: PMC3964216.
      8. Henson AL, Moore JB, Alard P, Wattenberg MM, Liu JM, Ellis SR. Mitochondrial function is impaired in yeast and human cellular models of Shwachman Diamond syndrome. Biochem Biophys Res Commun. 2013 Jul 19; 437(1):29-34. PMID: 23792098.
        View in: PubMed
      9. Sezgin G, Henson AL, Nihrane A, Singh S, Wattenberg M, Alard P, Ellis SR, Liu JM. Impaired growth, hematopoietic colony formation, and ribosome maturation in human cells depleted of Shwachman-Diamond syndrome protein SBDS. Pediatr Blood Cancer. 2013 Feb; 60(2):281-6. PMID: 22997148.
        View in: PubMed
      Max's Networks
      Related Concepts
      Derived automatically from this person's publications.
      People in Profiles who have published with this person.
      Related Authors
      People who share related concepts with this person.
      Back to TOP